- Early StageStartup in initial stages
- Top InvestorsThis company has received a significant amount of investment from top investors
- YC FundedStartup funded by Y Combinator
- Website
- Location
- Company size
- 1-10 people
- Total raised
- $1M
- Company type
- StartupNon-Profit
- Markets
Immunity Project careers
We are a Y Combinator (W14) backed non profit that is developing an HIV vaccine and distributing it worldwide for free.
If proven effective, our vaccine will turn those who receive it into HIV controllers. HIV controllers are naturally immune to HIV. ~1 out of 300 of those living with HIV have this ability. To develop our vaccine, we leveraged the work of accomplished computer scientists using statistical analysis to sift through blood samples from HIV controllers, identifying the virus surface targets favored by them. These targets were then formulated into a vaccine prototype.
We have completed a 400-mouse-study (details in additional info below; results submitted to a PRJ). We completed an ex-vivo study with human blood (video: youtu.be/lZKPbEM3oOY). Via single sphere phagocytosis of our HIV epitope loaded spheres, these antigen presenting cells will process the epitope, creating a Killer T cell immune response, attacking HIV at its weak points.
If proven effective, our vaccine will turn those who receive it into HIV controllers. HIV controllers are naturally immune to HIV. ~1 out of 300 of those living with HIV have this ability. To develop our vaccine, we leveraged the work of accomplished computer scientists using statistical analysis to sift through blood samples from HIV controllers, identifying the virus surface targets favored by them. These targets were then formulated into a vaccine prototype.
We have completed a 400-mouse-study (details in additional info below; results submitted to a PRJ). We completed an ex-vivo study with human blood (video: youtu.be/lZKPbEM3oOY). Via single sphere phagocytosis of our HIV epitope loaded spheres, these antigen presenting cells will process the epitope, creating a Killer T cell immune response, attacking HIV at its weak points.
Immunity Project hasn't added any jobs yet
Get notified when Immunity Project posts new jobs.
Co-Founder @Tari Labs • Co-Founder @Immunity Project • CEO @Sparkart • Investor @L., @Gyft, @Flexport , @Bellabeat, @Toymail, @Next Caller - YC Alum (W14)
CEO and Co-Founder @Immunity Project • Medical Director at @John Muir Medical Center • Studied at @Stanford University, @Massachusetts Institute of Technology, @University of California Berkeley
Total raised
$1M
Funded over
1 round
Latest round
Feb 2012
Marqeta • Remote • 7 days ago
Rockbot • Remote • 1 week ago
Updater • Remote • $150k – $200k • 2 weeks ago
Huge • Colombia • 2 weeks ago
Quartzy • Houston • 2 weeks ago